跳至主要内容
临床试验/CTRI/2018/03/012289
CTRI/2018/03/012289已完成2 期

Efficacy of Muqil as an Adjuvant in primary hypothyroidism-A randomized standard control trial

ational Institute of Unani medicine0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosed and Known cases of primary hypothyroidism with or without treatment
  • Patients having the TSH range between 10-20mu/l
  • Patients with Dyslipidemia associated with primary hypothyroidism.
  • Patients aged between 20-50 years
  • Patients of both genders.

排除标准

  • All cases of secondary hypothyroidism
  • Patient with systemic and metabolic illness other than primary hypothyroidism
  • Pregnant and lactating women
  • Patient <20 years of age and >50years of age.
  • Patient who fail to give consent.

研究者

发起方
ational Institute of Unani medicine

相似试验